J. I. Wolfsdorf and D. A. Weinstein, Glycogen storage diseases, Rev. Endocr. Metab. Disord, vol.4, pp.95-102, 2003.

H. O. Akman, A. Raghavan, and W. J. Craigen, Animal models of glycogen storage disorders, Prog. Mol. Biol. Transl. Sci, vol.100, pp.369-388, 2011.

H. S. Han, G. Kang, J. S. Kim, B. H. Choi, K. et al., Regulation of glucose metabolism from a liver-centric perspective, Exp. Mol. Med, vol.48, p.218, 2016.

M. M. Adeva-andany, M. González-lucán, C. Donapetry-garcía, C. Fernández-fernández, and E. Ameneiros-rodríguez, Glycogen metabolism in humans, BBA Clin, vol.5, pp.85-100, 2016.

J. Y. Chou and B. C. Mansfield, Mutations in the glucose-6-phosphatasealpha (G6PC) gene that cause type Ia glycogen storage disease, Hum. Mutat, vol.29, pp.921-930, 2008.

J. Y. Chou, D. Matern, B. C. Mansfield, C. , and Y. T. , Type I glycogen storage diseases: disorders of the glucose-6-phosphatase complex, Curr. Mol. Med, vol.2, pp.121-143, 2002.

S. W. Moses, Historical highlights and unsolved problems in glycogen storage disease type 1, Eur. J. Pediatr, vol.161, issue.1, pp.2-9, 2002.

H. Ozen, Glycogen storage diseases: new perspectives, World J. Gastroenterol, vol.13, pp.2541-2553, 2007.

P. S. Kishnani, S. L. Austin, J. E. Abdenur, P. Arn, D. S. Bali et al., Diagnosis and management of glycogen storage disease type I: a practice guideline of the American College of Medical Genetics and Genomics, American College of Medical Genetics and Genomics, vol.16, p.1, 2014.

M. Soty, A. Gautier-stein, F. Rajas, and G. Mithieux, Gut-brain glucose signaling in energy homeostasis, Cell Metab, vol.25, pp.1231-1242, 2017.
URL : https://hal.archives-ouvertes.fr/inserm-02339600

E. Mutel, A. Gautier-stein, A. Abdul-wahed, M. Amigó-correig, C. Zitoun et al., Control of blood glucose in the absence of hepatic glucose production during prolonged fasting in mice: induction of renal and intestinal gluconeogenesis by glucagon, Diabetes, vol.60, pp.3121-3131, 2011.

S. Sever, D. A. Weinstein, J. I. Wolfsdorf, R. Gedik, and E. J. Schaefer, , 2012.

, Glycogen storage disease type Ia: linkage of glucose, glycogen, lactic acid, triglyceride, and uric acid metabolism, J. Clin. Lipidol, vol.6, pp.596-600

M. Gjorgjieva, M. H. Oosterveer, G. Mithieux, and F. Rajas, Mechanisms by which metabolic reprogramming in GSD1 liver generates a favorable tumorigenic environment, J. Inborn Errors Metab. Screen, vol.4, p.2326409816679429, 2016.

L. M. Franco, V. Krishnamurthy, D. Bali, D. A. Weinstein, P. Arn et al., Hepatocellular carcinoma in glycogen storage disease type Ia: a case series, J. Inherit. Metab. Dis, vol.28, pp.153-162, 2005.

D. Q. Wang, L. M. Fiske, C. T. Carreras, and D. A. Weinstein, Natural history of hepatocellular adenoma formation in glycogen storage disease type I, J. Pediatr, vol.159, pp.442-446, 2011.

T. Iguchi, M. Yamagata, T. Sonoda, K. Yanagita, T. Fukahori et al., Malignant transformation of hepatocellular adenoma with bone marrow metaplasia arising in glycogen storage disease type I: a case report, Mol. Clin. Oncol, vol.5, pp.599-603, 2016.

D. Cassiman, L. Libbrecht, C. Verslype, W. Meersseman, R. Troisi et al., An adult male patient with multiple adenomas and a hepatocellular carcinoma: mild glycogen storage disease type Ia, J. Hepatol, vol.53, pp.213-217, 2010.

J. Calderaro, P. Labrune, G. Morcrette, S. Rebouissou, D. Franco et al., Molecular characterization of hepatocellular adenomas developed in patients with glycogen storage disease type I, J. Hepatol, vol.58, pp.350-357, 2013.

C. P. Sentner, I. J. Hoogeveen, D. A. Weinstein, R. Santer, E. Murphy et al., Glycogen storage disease type III: diagnosis, genotype, management, clinical course and outcome, J. Inherit. Metab. Dis, vol.39, pp.697-704, 2016.

P. S. Kishnani, S. L. Austin, P. Arn, D. S. Bali, A. Boney et al., Glycogen storage disease type III diagnosis and management guidelines, Genet. Med, vol.12, pp.446-463, 2010.

J. J. Shen, C. , and Y. T. , Molecular characterization of glycogen storage disease type III, Curr. Mol. Med, vol.2, pp.167-175, 2002.

A. V. Bernier, C. P. Sentner, C. E. Correia, D. W. Theriaque, J. J. Shuster et al., Hyperlipidemia in glycogen storage disease type III: effect of age and metabolic control, J. Inherit. Metab. Dis, vol.31, pp.729-732, 2008.

K. M. Liu, J. Y. Wu, C. , and Y. T. , Mouse model of glycogen storage disease type III, Mol. Genet. Metab, vol.111, pp.467-476, 2014.

S. Pagliarani, S. Lucchiari, G. Ulzi, R. Violano, M. Ripolone et al., Glycogen storage disease type III: a novel Agl knockout mouse model, Biochim. Biophys. Acta, vol.1842, pp.2318-2328, 2014.

E. B. Haagsma, G. P. Smit, K. E. Niezen-koning, A. S. Gouw, L. Meerman et al., Type IIIb glycogen storage disease associated with end-stage cirrhosis and hepatocellular carcinoma, The Liver Transplant Group, vol.25, pp.537-540, 1997.

M. Siciliano, E. De-candia, S. Ballarin, F. M. Vecchio, S. Servidei et al., Hepatocellular carcinoma complicating liver cirrhosis in type IIIa glycogen storage disease, J. Clin. Gastroenterol, vol.31, pp.80-82, 2000.

E. Demo, D. Frush, M. Gottfried, J. Koepke, A. Boney et al., Glycogen storage disease type III-hepatocellular carcinoma a long-term complication?, J. Hepatol, vol.46, pp.492-498, 2007.

E. Mutel, A. Abdul-wahed, N. Ramamonjisoa, A. Stefanutti, I. Houberdon et al., Targeted deletion of liver glucose-6 phosphatase mimics glycogen storage disease type 1a including development of multiple adenomas, J. Hepatol, vol.54, pp.529-537, 2011.
URL : https://hal.archives-ouvertes.fr/hal-00575314

B. E. Bachrach, D. A. Weinstein, M. Orho-melander, A. Burgess, and J. I. Wolfsdorf, Glycogen synthase deficiency (glycogen storage disease type 0) presenting with hyperglycemia and glucosuria: report of three new mutations, J. Pediatr, vol.140, pp.781-783, 2002.

A. Nessa, A. Kumaran, R. Kirk, A. Dalton, D. Ismail et al., Mutational analysis of the GYS2 gene in patients diagnosed with ketotic hypoglycaemia, J. Pediatr. Endocrinol. Metab, vol.25, pp.963-967, 2012.

C. S. Kasapkara, Z. Aycan, E. Aço-glu, S. Senel, M. M. Oguz et al., The variable clinical phenotype of three patients with hepatic glycogen synthase deficiency, J. Pediatr. Endocrinol. Metab, vol.30, pp.459-462, 2017.

D. D. Koeberl, P. S. Kishnani, D. Bali, C. , and Y. T. , Emerging therapies for glycogen storage disease type I, Trends Endocrinol. Metab, vol.20, pp.252-258, 2009.

K. Bhattacharya, Investigation and management of the hepatic glycogen storage diseases, Transl. Pediatr, vol.4, pp.240-248, 2015.

V. Valayannopoulos, F. Bajolle, J. B. Arnoux, S. Dubois, N. Sannier et al., Successful treatment of severe cardiomyopathy in glycogen storage disease type III With D,L-3-hydroxybutyrate, ketogenic and high-protein diet, Pediatr. Res, vol.70, pp.638-641, 2011.

H. Yi, E. D. Brooks, B. L. Thurberg, J. C. Fyfe, P. S. Kishnani et al., Correction of glycogen storage disease type III with rapamycin in a canine model, J. Mol. Med. (Berl.), vol.92, pp.641-650, 2014.

A. I. Dagli and D. A. Weinstein, Glycogen storage disease type VI, 2009.

A. Roscher, J. Patel, S. Hewson, L. Nagy, A. Feigenbaum et al., natural history of glycogen storage disease types VI and IX: Long-term outcome from the largest metabolic center in Canada, The www.moleculartherapy.org Molecular Therapy, vol.26, pp.171-176, 2014.

S. L. Austin, A. D. Proia, M. J. Spencer-manzon, J. Butany, S. B. Wechsler et al., Cardiac pathology in glycogen storage disease type III, JIMD Rep, vol.6, pp.65-72, 2012.

E. A. Mogahed, M. Y. Girgis, R. Sobhy, H. Elhabashy, O. M. Abdelaziz et al., Skeletal and cardiac muscle involvement in children with glycogen storage disease type III, Eur. J. Pediatr, vol.174, pp.1545-1548, 2015.

T. Khan, H. Weber, J. Dimuzio, A. Matter, B. Dogdas et al., Silencing myostatin using cholesterolconjugated siRNAs induces muscle growth, Mol. Ther. Nucleic Acids, vol.5, p.342, 2016.

Y. T. Chen, Type I glycogen storage disease: kidney involvement, pathogenesis and its treatment, Pediatr. Nephrol, vol.5, pp.71-76, 1991.

D. Liu, C. Li, Y. Chen, C. Burnett, X. Y. Liu et al., Nuclear import of proinflammatory transcription factors is required for massive liver apoptosis induced by bacterial lipopolysaccharide, J. Biol. Chem, vol.279, pp.48434-48442, 2004.